Immune-mediated dormancy: An equilibrium with cancer

Journal of Leukocyte Biology

Volumn 84, Issue 4, 2008, Pages 988-993

  Teng, Michele W L ^a   Swann, Jeremy B ^a   Koebel, Catherine M ^b   Schreiber, Robert D ^b   Smyth, Mark J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Elimination; Escape; Immunoediting

Indexed keywords

IMMUNOGLOBULIN;

ADAPTIVE IMMUNITY; ADOPTIVE IMMUNOTHERAPY; B CELL LEUKEMIA; B CELL LYMPHOMA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER IMMUNIZATION; CANCER THERAPY; CARCINOGENESIS; CD8+ T LYMPHOCYTE; CELL THERAPY; CELL TRANSFORMATION; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; DORMANCY; GENE EXPRESSION PROFILING; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOGENICITY; IMMUNOSURVEILLANCE; INNATE IMMUNITY; NONHUMAN; ONCOGENE; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; SPLENOMEGALY; T LYMPHOCYTE; TUMOR IMMUNITY;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE SYSTEM; INTERFERON TYPE II; INTERLEUKIN-12; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; T-LYMPHOCYTES; TUMOR ESCAPE;

EID: 53549123079     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1107774     Document Type: Conference Paper

References (44)

1. Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., Schreiber, R. D. (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3, 991-998.
2. Stutman, O. (1974) Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice. Science 183, 534-536.
3. Stutman, O. (1975) Immunodepression and malignancy. Adv. Cancer Res. 22, 261-422.
4. Dighe, A. S., Richards, E., Old, L. J., Schreiber, R. D. (1994) Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN γ receptors. Immunity 1, 447-456.
5. Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., Schreiber, R. D. (1998) Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 95, 7556-7561.
6. Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., Schreiber, R. D. (2001) IFNγ and lymphocytes prevent primary tumor development and shape tumor immunogenicity. Nature 410, 1107-1111.
7. Dunn, G. P., Koebel, C. M., Schreiber, R. D. (2006) Interferons, immunity and cancer immunoediting. Nat. Rev. Immunol. 6, 836-848.
8. Smyth, M. J., Thia, K. Y., Street, S. E., MacGregor, D., Godfrey, D. I., Trapani, J. A. (2000) Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J. Exp. Med. 192, 755-760.
9. Dunn, G. P., Old, L. J., Schreiber, R. D. (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137-148.
10. Dunn, G. P., Old, L. J., Schreiber, R. D. (2004) The three Es of cancer immunoediting. Annu. Rev. Immunol. 22, 329-360.
11. Swann, J. B., Smyth, M. J. (2007) Immune surveillance of tumors. J. Clin. Invest. 117, 1137-1146.
12. Muller, A. J., Scherle, P. A. (2006) Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors. Nat. Rev. Cancer 6, 613-625.
13. Weinhold, K. J., Miller, D. A., Wheelock, E. F. (1979) The tumor dormant state. Comparison of L5178Y cells used to establish dormancy with those that emerge after its termination. J. Exp. Med. 149, 745-757.
14. Matsuzawa, A., Takeda, Y., Narita, M., Ozawa, H. (1991) Survival of leukemic cells in a dormant state following cyclophosphamide-induced cure of strongly immunogenic mouse leukemia (DL811). Int. J. Cancer 49, 303-309.
15. Weinhold, K. J., Goldstein, L. T., Wheelock, E. F. (1979) The tumor dormant state. Quantitation of L5178Y cells and host immune responses during the establishment and course of dormancy in syngeneic DBA/2 mice. J. Exp. Med. 149, 732-744.
16. Farrar, J. D., Katz, K. H., Windsor, J., Thrush, G., Scheuermann, R. H., Uhr, J. W., Street, N. E. (1999) Cancer dormancy. VII. A regulatory role for CD8+ T cells and IFN-γ in establishing and maintaining the tumor-dormant state. J. Immunol. 162, 2842-2849.
17. Vitetta, E. S., Tucker, T. F., Racila, E., Huang, Y. W., Marches, R., Lane, N., Scheuermann, R. H., Street, N. E., Watanabe, T., Uhr, J. W. (1997) Tumor dormancy and cell signaling. V. Regrowth of the BCL1 tumor after dormancy is established. Blood 89, 4425-4436.
18. Morecki, S., Pugatsch, T., Levi, S., Moshel, Y., Slavin, S. (1996) Tumor-cell vaccination induces tumor dormancy in a murine model of B-cell leukemia/lymphoma (BCL1). Int. J. Cancer 65, 204-208.
19. Rabinovsky, R., Uhr, J. W., Vitetta, E. S., Yefenof, E. (2007) Cancer dormancy: lessons from a B cell lymphoma and adenocarcinoma of the prostate. Adv. Cancer Res. 97, 189-202.
20. Granziero, L., Krajewski, S., Farness, P., Yuan, L., Courtney, M. K., Jackson, M. R., Peterson, P. A., Vitiello, A. (1999) Adoptive immunotherapy prevents prostate cancer in a transgenic animal model. Eur. J. Immunol. 29, 1127-1138.
21. Mahnke, Y. D., Schwendemann, J., Beckhove, P., Schirrmacher, V. (2005) Maintenance of long-term tumor-specific T-cell memory by residual dormant tumor cells. Immunology 115, 325-336.
22. Feuerer, M., Rocha, M., Bai, L., Umansky, V., Solomayer, E. F., Bastert, G., Diel, I. J., Schirrmacher, V. (2001) Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients. Int. J. Cancer 92, 96-105.
23. Müller, M., Gounari, F., Prifti, S., Hacker, H. J., Schirrmacher, V., Khazaie, K. (1998) EblacZ tumor dormancy in bone marrow and lymph nodes: active control of proliferating tumor cells by CD8+ immune T cells. Cancer Res. 58, 5439-5446.
24. Loeser, S., Loser, K., Bijker, M. S., Rangachari, M., van der Burg, S. H., Wada, T., Beissert, S., Melief, C. J., Penninger, J. M. (2007) Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells. J. Exp. Med. 204, 879-891.
25. Stewart, T. H., Hollinshead, A. C., Raman, S. (1991) Tumor dormancy: initiation, maintenance and termination in animals and humans. Can. J. Surg. 34, 321-325.
26. Sagalowsky, A. I., Molberg, K. (1999) Solitary metastasis of renal cell carcinoma to the contralateral adrenal gland 22 years after nephrectomy. Urology 54, 162.
27. Herrlinger, U., Hebart, H., Kanz, L., Dichgans, J., Weller, M. (2005) Relapse of primary CNS lymphoma after more than 10 years in complete remission. J. Neurol. 252, 1409-1410.
28. Demicheli, R., Abbattista, A., Miceli, R., Valagussa, P., Bonadonna, G. (1996) Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy. Breast Cancer Res. Treat. 41, 177-185.
29. Callaway, M. P., Briggs, J. C. (1989) The incidence of late recurrence (greater than 10 years); an analysis of 536 consecutive cases of cutaneous melanoma. Br. J. Plast. Surg. 42, 46-49.
30. Matsui, K., Sawa, T., Suzuki, H., Nakagawa, K., Okamoto, N., Tada, T., Nagano, T., Masuda, N. (2006) Relapse of stage I small cell lung cancer ten or more years after the start of treatment. Jpn. J. Clin. Oncol. 36, 457-461.
31. Karrison, T. G., Ferguson, D. J., Meier, P. (1999) Dormancy of mammary carcinoma after mastectomy. J. Natl. Cancer Inst. 91, 80-85.
32. Pfitzenmaier, J., Ellis, W. J., Arfman, E. W., Hawley, S., McLaughlin, P. O., Lange, P. H., Vessella, R. L. (2006) Telomerase activity in disseminated prostate cancer cells. BJU Int. 97, 1309-1313.
33. Weckermann, D., Muller, P., Wawroschek, F., Harzmann, R., Riethmuller, G., Schlimok, G. (2001) Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer: detection and prognostic value. J. Urol. 166, 699-703.
34. Meng, S., Tripathy, D., Frenkel, E. P., Shete, S., Naftalis, E. Z., Huth, J. F., Beitsch, P. D., Leitch, M., Hoover, S., Euhus, D., Haley, B., Morrison, L., Fleming, T. P., Herlyn, D., Terstappen, L. W., Fehm, T., Tucker, T. F., Lane, N., Wang, J., Uhr, J. W. (2004) Circulating tumor cells in patients with breast cancer dormancy. Clin. Cancer Res. 10, 8152-8162.
35. Kauffman, H. M., McBride, M. A., Delmonico, F. L. (2000) First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer. Transplantation 70, 1747-1751.
36. Myron Kauffman, H., McBride, M. A., Cherikh, W. S., Spain, P. C., Marks, W. H., Roza, A. M. (2002) Transplant tumor registry: donor related malignancies. Transplantation 74, 358-362.
37. Felsher, D. W. (2006) Tumor dormancy: death and resurrection of cancer as seen through transgenic mouse models. Cell Cycle 5, 1808-1811.
38. Reichard, K. K., Zhang, Q. Y., Sanchez, L., Hozier, J., Viswanatha, D., Foucar, K. (2006) Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: case report and review of the literature. Am. J. Hematol. 81, 178-185.
39. Davis, T. A., Maloney, D. G., Czerwinski, D. K., Liles, T. M., Levy, R. (1998) Anti-idiotype antibodies can induce long-term complete remissions in non-Hodgkin's lymphoma without eradicating the malignant clone. Blood 92, 1184-1190.
40. Montagna, D., Maccario, R., Locatelli, F., Montini, E., Pagani, S., Bonetti, F., Daudt, L., Turin, I., Lisini, D., Garavaglia, C., Dellabona, P., Casorati, G. (2006) Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemia. Blood 108, 3843-3850.
41. Roepman, P., Wessels, L. F., Kettelarij, N., Kemmeren, P., Miles, A. J., Lijnzaad, P., Tilanus, M. G., Koole, R., Hordijk, G. J., van der Vliet, P. C., Reinders, M. J., Slootweg, P. J., Holstege, F. C. (2005) An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat. Genet. 37, 182-186.
42. Aguirre-Ghiso, J. A. (2007) Models, mechanisms and clinical evidence for cancer dormancy. Nat. Rev. Cancer 7, 834-846.
43. Koebel, C. M., Vermi, W., Swann, J. B., Zerafa, N., Rodig, S. J., Old, L. J., Smyth, M. J., Schreiber, R. D. (2007) Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450, 903-907.
44. Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., Lowe, S. W. (2007) Senescence and tumor clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656-660.